Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BI-4020 |
Synonyms | |
Therapy Description |
BI-4020 is a 4th-generation EGFR inhibitor, with activity against EGFR T790M and C797S, which potentially inhibits tumor growth (PMID: 38396251). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BI-4020 | BI4020|BI 4020 | EGFR Inhibitor 4th gen 16 | BI-4020 is a 4th-generation EGFR inhibitor, with activity against EGFR T790M and C797S, which potentially inhibits tumor growth (PMID: 38396251). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|